Expert Review of Hematology 2012-04-01

Bioengineered factor Xa as a potential new strategy for hemophilia therapy.

Rodney M Camire

Index: Expert Rev. Hematol. 5(2) , 121-3, (2012)

Full Text: HTML

Abstract

Structure	Name/CAS No.	Molecular Formula	Articles
	Factor V Activating Enzyme CAS:65522-14-7

Structural basis of thrombin-mediated factor V activation: t...
2011-06-30
[Blood 117(26) , 7164-73, (2011)]

Phosphatidylserine-induced factor Xa dimerization and bindin...
2013-01-08
[Biochemistry 52(1) , 143-51, (2013)]

Modulation of prothrombinase assembly and activity by phosph...
2011-10-14
[J. Biol. Chem. 286(41) , 35535-42, (2011)]

Structural basis of coagulation factor V recognition for cle...
2011-10-03
[FEBS Lett. 585(19) , 3020-5, (2011)]

Crystallization and preliminary X-ray crystallographic analy...
2009-12-01
[Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65(Pt 12) , 1306-8, (2009)]

Bioengineered factor Xa as a potential new strategy for hemophilia therapy.

Abstract

Related Compounds